Skip to main content

Published locations for Etokimab trial highlights IL-33 targeting as potential new AD therapy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Etokimab trial highlights IL-33 targeting as potential new AD therapy

User login

  • Reset your password
  • /content/etokimab-trial-highlights-il-33-targeting-potential-new-ad-therapy
  • /edermatologynews/article/210739/atopic-dermatitis/etokimab-trial-highlights-il-33-targeting
  • /dermatology/article/210739/atopic-dermatitis/etokimab-trial-highlights-il-33-targeting-potential-new